← Back to Search

Radiation Therapy

Cohort A for Brain Tumor

N/A
Waitlist Available
Led By Kevin R. Shiue, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial is designed to test two de-escalated whole brain radiation therapy (WBRT) dose levels and assess their ability to maintain acceptable in-brain distant control.

Eligible Conditions
  • Metastatic Brain Tumors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
In-brain distant failure rate
Secondary outcome measures
Change in health-related quality of life
Change in neurocognitive function
Change in performance status
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Cohort BExperimental Treatment1 Intervention
Low PCI dose
Group II: Cohort AExperimental Treatment1 Intervention
Standard PCI dose
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cohort A
2020
Completed Phase 2
~120
Cohort B
2020
Completed Phase 1
~90

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
983,141 Total Patients Enrolled
Kevin R. Shiue, MDPrincipal InvestigatorIndiana University School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the utmost number of individuals participating in this exploration?

"Affirmative. Clinicaltrials.gov displays that this medical trial, which debuted on July 6th 2017, is still recruiting participants. 40 people have to be enrolled from 3 separate clinical sites."

Answered by AI

Are there presently any vacancies for this therapeutic trial?

"According to the clinicaltrials.gov database, this medical experiment is actively accepting participants and was initially published on July 6th 2017 before being updated most recently on September 20th 2022."

Answered by AI
~3 spots leftby Apr 2025